Wikipedia -WSS

Wikipedia

author：Wikipedia 2025-09-28 08:53:43 - browse：51

Stock exchange — Drew Angerer/Getty Images

Sage Therapeutics said Monday that it may need to reduce costs, including through employee layoffs, following the Food and Drug Administration’s denial of its rapid-acting drug for major depressive disorder.

On Friday, the agency granted market clearance for the drug, called Zurzuvae, to treat women with postpartum depression, a smaller commercial market. Sage failed to convince regulators to also approve the drug for depression, a broader condition.

“We don’t agree with the FDA review,” Sage CEO Barry Greene said during an earnings call, a point he made repeatedly. “We are evaluating the [FDA’s response letter] and as soon as we can provide more clarity, we will, on what the next steps are.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： How one medical school became remarkably diverse
Next article： Mystery swirls around US soldier who entered North Korea days ago, officials say

hotspot

WSS

FDA panel unanimously endorses Eisai’s Alzheimer’s drug Leqembi

5 dead in mass shooting on Caribbean island of St. Vincent: Police

Adopting new red light myopia treatments may be short

Are infertility treatments 'essential' during the Covid

US jobless claims fall again as labor market continues to flash strength

340B reform proposal comes out of Senate working group

focus

Wikipedia

hotspot

The cancer drug shortage isn’t new — and neither are the solutions

Why Novartis is going to walk from its acquisition of MorphoSys

Activists slam private health insurers over coverage restrictions

Texas Medical Board asked to define abortion emergency exception

Medicare proposal to cover medical devices draws a mixed reaction

When a patient nears the end, a feared therapy can comfort

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

How a Boston hospital is priming medical residents to use GPT

23andMe had bad news about my health. I wish a person had delivered it

Updated Covid vaccine has 54% effectiveness, new study suggests

leisure time

Telehealth startups are trying to fill the menopause care vacuum

Sanders wants to replace patents with prizes for drug inventions

Readout Newsletter: Amgen, Regeneron, BGI Group and more

Gene therapy for Afghan refugees’ infant will be fully covered

Devoted Health’s losses in Medicare Advantage persist

Delta passengers in Vegas fall sick while waiting on flight in triple

knowledge

entertainment

hotspot

focus